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Neurons arise in the adult forebrain subventricular
zone (SVZ) from Type B neural stem cells (NSCs),
raising considerable interest in the molecules that
maintain this life-long neurogenic niche. Type B cells
are anchored by specialized apical endfeet in the
center of a pinwheel of ependymal cells. Here we
show that the apical endfeet express high levels
of the adhesion and signaling molecule vascular
cell adhesion molecule-1 (VCAM1). Disruption of
VCAM1 in vivo causes loss of the pinwheels, disrup-
ted SVZ cytoarchitecture, proliferation and depletion
of the normally quiescent apical Type B cells, and
increased neurogenesis in the olfactory bulb, dem-
onstrating a key role in niche structure and function.
We show that VCAM1 signals via NOX2 production
of reactive oxygen species (ROS) to maintain NSCs.
VCAM1 on Type B cells is increased by IL-1b,
demonstrating that it can act as an environmental
sensor, responding to chemokines involved in tissue
repair.
INTRODUCTION
The SVZ of the lateral ventricle in the adult brain harbors
NSCs that continue to generate new neurons throughout life,
and it is the largest neurogenic niche in the adult brain (Doetsch
and Alvarez-Buylla, 1996). Prior work has shown that the SVZ
lineage is initiated from slowly dividing Type B NSCs, which
produce the transit-amplifying Type C cells that in turn produce
Type A neuroblasts, and these migrate anteriorly along the
rostral migratory stream (RMS), eventually differentiating into
neurons that incorporate into olfactory bulb circuits (Alvarez-
Buylla et al., 2001).
Recent studies have begun to elucidate the 3D structure of this
adult stem cell niche. The germinal zone, which is only approxi-
mately 50 mm thick, is sandwiched between two layered struc-
tures: on the parenchymal side, the SVZ is bounded by an exten-220 Cell Stem Cell 11, 220–230, August 3, 2012 ª2012 Elsevier Inc.sive planar network of blood vessels, the SVZ plexus, and on the
ventricular side, by the layer of ciliated ependymal cells (Kazanis
et al., 2010; Luo et al., 2008; Mirzadeh et al., 2008; Shen et al.,
2008; Tavazoie et al., 2008). A subpopulation of Type B cells
have apical processes that penetrate the ependymal layer, and
some of these also have a basal process projecting onto the
SVZ plexus blood vessels, thus spanning these two important
humoral compartments (Mirzadeh et al., 2008; Shen et al.,
2008). The apical processes are typically in groups, arising
from a cluster of Type B cells, and the adjacent ependymal cells
form a pinwheel around this center, like petals around the central
stigma in an inflorescence; these pinwheels are specific to the
striatal germinal zone (Mirzadeh et al., 2008) (Figure 1). Thus,
by interacting with the ependymal layer, the apical processes
of Type B cells could serve as anchors to provide structural
integrity to the niche, and they are positioned perfectly to sense
changes in signals in the adjacent humoral compartment, the
cerebrospinal fluid (CSF).
In prior studies, we demonstrated that NSCs can home to the
SVZ vascular plexus using molecules that also are important in
hematopoietic stem cell (HSC) homing: stromal differentiation
factor-1 (SDF1) and its receptor, chemokine (C-X-C motif) re-
ceptor 4 (CXCR4) (Kokovay et al., 2010). However, as yet, the
molecules responsible for positioning and holding the apical
endfeet of Type B cells within the ependymal layer are not
known. In the bone marrow, once HSCs home to the bone
marrow niche attracted by SDF1/CXCR4, they are held in place
by binding to VCAM1, expressed on the surface of bone marrow
stromal cells (Lapidot et al., 2005; Papayannopoulou et al.,
1995). VCAM1 expression is upregulated in response to cyto-
kines, increasing adhesion of HSCs in the bone marrow niche
(Simmons et al., 1992). Given that the importance of SDF1/
CXCR4 for stem cell homing is conserved between blood and
brain, we investigated whether VCAM1 function is similarly
conserved in the brain niche.
Strikingly, we found that bright anti-VCAM1 staining is located
on the endfeet of Type B cells in the center of pinwheels. Block-
ing VCAM1 function severely disrupted the niche structure, with
loss of the pinwheels, massive activation of the quiescent Type
B cells, and consequent depletion of the NSC population.
Hence, we identify VCAM1 as a key molecule responsible for
Figure 1. VCAM1 Is Expressed on the Apical Processes of Type B Cells
(A) VCAM1 (red) is strongly expressed on the surface of the striatal side of the lateral ventricle and the dorsal wedge (arrow), but not on themedial or septal side or
in the overlying corpus callosum, as shown in this low-magnification image of a coronal section.
(B) High-magnification image of a coronal section showing bright punctate VCAM1 expression (green) on GFAP+ (red) processes. The GFAP+ cells have thin
radial processes (arrows in lower panel).
(C) En face view of the SVZ wholemount showing VCAM1+ (red) staining in the center of ependymal pinwheels revealed by b-catenin (blue).
(D) Immunocytochemistry of VCAM1 (green) and GFAP (red) showing polarized membrane expression on cultured SVZ cells. Blue, DAPI nuclear staining.
(E) High-magnification confocal projection image angled 45 showing VCAM1 (red) cupping GFAP processes.
(F) High-magnification confocal image of the most superficial layer of the SVZ wholemount showing VCAM1 (red) on GFAP (green) cells in the center of pinwheel
structures revealed by anti-b-catenin (white). LV, lateral ventricle; stm, striatum; cc, corpus callosum; sept, septum. Scale bars: 20 mm. See also Figure S1.
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state.
RESULTS
VCAM1 IsConcentrated on theApical Processes of Type
B Cells in the Adult Mouse SVZ
VCAM1, also known as CD106, is a member of the immunoglo-
bin (Ig) superfamily. It is a cell surface sialoglycoprotein first
identified on cytokine-activated endothelium (Osborn et al.,
1989). By immunohistochemistry of coronal sections, confirmed
by in situ hybridizations (Figure S1 available online), we
observed strong punctate staining of VCAM1 along the striatal
side of the ventricular wall and the dorso-lateral edge of the
SVZ, which contains many aligned neuroblast chains flowing
into the RMS, but not on the septal side of the ventricular wall
(Figure 1A), indicating specific expression in the neurogenic
niche. Double immunolabeling showed that all of the VCAM1+
punctate structures near the ventricular surface were associated
with GFAP+ cells (n = 134 cells), and high magnification revealed
that these structures were the apical endfeet of GFAP+ Type B
cells, which penetrate into the ependymal layer and protrude (to
varying extents) into the lateral ventricle (Figure 1B). These
VCAM1+ GFAP+ cells typically extended radial processesCbasally into the SVZ toward the SVZ plexus layer (Figure 1B,
arrows).
In order to understand better the VCAM1+ endfeet structures
in relation to the SVZ cytoarchitecture, we immunostained SVZ
wholemounts, an organotypic preparation of the SVZ in which
the normal 3D cell-cell relationships are preserved (Doetsch
et al., 1999a). When viewed en face from the ventricular side,
a distinctive pattern of staining emerged that was visible with
different VCAM1 antibodies. Using anti-b-catenin to reveal the
ependymal junctions in the SVZ wholemounts, we saw that the
VCAM1+ endfeet were intermingled in the ependymal layer,
singly or in groups, sometimes of more than 10 (Figure 1C). Inter-
estingly, polarized VCAM1+ staining was visible on the mem-
brane of cultured, elongated GFAP+ adult SVZ cells, (Figure 1D),
indicating that asymmetric localization of VCAM1 can be
preserved in vitro. In wholemounts immunostained for GFAP,
the VCAM1+ endfeet typically overlapped or abutted GFAP+
elements in the center of the pinwheels (Figures 1E and 1F).
Advancing from this surface layer down into the SVZ tissue,
most of the VCAM1 staining disappeared rapidly, and the vast
majority of Type C cells, revealed by Tomato fluorescence
in a Mash1-Cre-Tomato mouse (Ascl1tm1.1(cre/ERT2); B6.Cg-
Gt(ROSA)26Sortm9(CAG-tdTomato)) (Kim et al., 2011) (Figure S1),
or staining for the oligodendrocyte transcription factor 2ell Stem Cell 11, 220–230, August 3, 2012 ª2012 Elsevier Inc. 221
Figure 2. Blocking VCAM1 Disrupts the Type B and Ependymal Cytoarchitecture
(A and B) Confocal images of the SVZ wholemount stained for b-catenin (green) to reveal the ependymal layer, and stained for GFAP (red) to reveal the Type B
cells, comparing the effect of control antibody infusion (A) with that of infusion of VCAM1 blocking antibody (B) for 6 days in vivo.
(C) Images illustrating the dramatic changes in GFAP+ processes using wholemounts from a GFAP-GFP (green) transgenic mouse also immunostained for GFAP
(red) after VCAM1 blocking or control antibody treatment.
(D) Increased GFAP-GFP+ (green) Ki67+ (red) cells following VCAM1 block.
(E) Quantification of (D).
(F) The number of GFAP-GFP+ apical Type B cells is significantly reduced by VCAM1 block.
(G) Quantification of EdU+ cells in the olfactory bulb, 3 weeks after pump removal and EdU injection.
(H) Quantification of EdU+ cells in the SVZ. Scale bars: 20 mm. Error bars = SEM. See also Figure S2.
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cells (not shown). Thus, VCAM1 expression is rapidly downregu-
lated with lineage progression.
Blocking VCAM1 Disrupts the Position and Function of
Cells in the SVZ Niche
The specific expression pattern of VCAM1, which has known
adhesion properties, suggested it could be important in main-
taining Type B cell position, with their apical processes interca-
lated in the ependymal layer. To test whether inhibiting VCAM1
function would disrupt the niche architecture, we used an222 Cell Stem Cell 11, 220–230, August 3, 2012 ª2012 Elsevier Inc.osmotic minipump to continuously deliver VCAM1 blocking anti-
body or isotype control antibody into the lateral ventricle of
hGFAP-GFP mice for 6 days, then examined the resulting SVZ
wholemounts.
Inspection of the ependymal layer showed a dramatic effect
of blocking VCAM1. In the SVZs from animals treated with iso-
type control antibodies, b-catenin staining revealed the normal
honeycomb-like pattern and a recognizable pinwheel arrange-
ment of ependymal cells around concentrations of GFAP+ pro-
cesses (Figure 2A). In contrast, the SVZs from animals treated
with VCAM1 blocking antibodies showed pockets of severe
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b-catenin staining and bundles of GFAP+ processes, with loss of
many of the basic pinwheel structures (Figure 2B). Interestingly,
in addition to an increase in b-catenin, which could indicate an
increase in adherens junctions, we observed upregulation of
the tight junction protein ZO-1 in VCAM1-blocking-antibody-
treated mice (Figure S2). This suggests that perturbations in
SVZ cell-cell interactions could contribute to the observed
increase in Type B cell division.
Disruption was also seen in the GFAP+ apical Type B cell pop-
ulation located just beneath the ependymal layer (Figures 2B
and 2C). The number of GFAP-GFP+ cell bodies was dramati-
cally reduced, to 44.8% of control (control, 1,915 ± 292.6 versus
858.2 ± 237.2 after VCAM1 block, p < 0.03) (Figures 2B and 2F),
and their processes, normally beautifully aligned, especially in
the dorsal aspect of the SVZ, were disarrayed and shorter (Fig-
ure 2C). Blocking VCAM1 did not increase apoptotic cell death,
so that is unlikely to be the cause of theGFAP+ cell loss (caspase
3 staining, not shown). Type B cells situated at the apical surface
rarely divide (Doetsch et al., 1997, 1999a, 1999b; Mirzadeh et al.,
2008; Morshead et al., 1994; Shen et al., 2008), supporting
the concept that the ependymal layer forms a quiescent niche
for these cells. Notably, VCAM1 inhibition stimulated apical
GFAP+ Type B cell proliferation, so that there were significantly
more GFAP/Ki67-double positive cells within 9 mm of the epen-
dymal layer where the majority of Type B cells reside (Doetsch
et al., 1997; Mirzadeh et al., 2008; Shen et al., 2008) (7-fold
increase from 3.46%± 1.49% in control to 22.85%± 5.76%after
anti-VCAM1 treatment, p < 0.02, Figures 2D and 2E). The
number of MASH1+ Type C cells in the SVZ after 6 days of block-
ing VCAM1 was reduced, although not significantly (44.51 ±
12.60 for control versus 28.65 ± 5.34 for anti-VCAM1, average
cells per stack, p = 0.28) (Figure S2).
We labeled cells in S phase by injectingmice with EdU on days
4, 5, and 6 after insertion of pumps with VCAM1 or control anti-
body, and we let the mice survive for 3 more weeks as a chase
period. The EdU label is retained by newborn neurons that
migrate to the olfactory bulb and by slowly dividing progenitor
cells that remain in the SVZ, which are thought to represent
dormant stem cells (Johansson et al., 1999). Blocking VCAM1
resulted in more cells leaving the SVZ and migrating to the olfac-
tory bulb (VCAM1 block, 146.8 ± 25.16 EdU+ cells/field in the
olfactory bulb; control, 82.48 ± 5.55, p < 0.05). In contrast there
were significantly fewer label-retaining cells left in the SVZ
(VCAM1 block, 5.05 ± 0.87 EdU+ cells in the SVZ; VCAM1 block,
12.85 ± 0.78, p < 0.0006 Figures 2G and 2H).
These results show that VCAM1 is critical for the organization
of Type B cells and ependymal cells at the ventricular surface
and suggest that blocking VCAM1 results in loss of the more
quiescent ependymal niche, with activation of Type B cells to
a proliferative state. The trend toward fewer transit amplifying
Type C cells after 1 week and more olfactory neurons indicates
rapid depletion of the early stages of the lineage and increased
migration out of the SVZ.
Inhibiting VCAM1 Function Disrupts Neuroblast Chain
Migration
In several wholemount preparations we found that neuroblast
chains in the SVZ were severely disrupted after VCAM1 functionCwas blocked, with abnormal clumps of DCX+ neuroblasts visible
even at low magnification, and denuded areas where chains
were severely reduced (Figure 3A). Confocal imaging revealed
that DCX+ cells were bunched together, wrapped by disorga-
nized Type B cells (Figures 3B and 3C). Interestingly, in sagittal
sections we also observed several patches of neuroblast chains
outside the SVZ in the striatal parenchyma (Figure 3D, arrow). As
we did not see expression of VCAM1 on neuroblasts in vivo (Fig-
ure S1), disruption of neuroblast chains is most likely indirect.
Neuroblast disruption could be due to disorganization of the
associated GFAP+ processes, or to disruption of the ependymal
cilia that normally direct neuroblast chain migration (Sawamoto
et al., 2006); indeed, after treatment with VCAM1-blocking anti-
body, there were patches in the SVZ where cilia were disorga-
nized or absent (Figure S3).
VCAM1 Is Required for NSC Maintenance
Given that Type B NSCs rather specifically express VCAM1, and
given its ability to act as a signaling molecule in other systems,
we investigated whether VCAM1 function impacted cardinal
features of NSC behavior, including self-renewal and the ability
to produce differentiated progeny. We generated a lentiviral
vector expressing Vcam1 shRNA that gave over 90% transduc-
tion and reduced the Vcam1 level in adult SVZ cells to 59.61% ±
.02% of empty vector (EV) control (Figure 4A). We tested the
impact of reducing Vcam1 levels on neurosphere formation
under conditions that enable a measure of NSC self-renewal
(Pastrana et al., 2011), and on cells plated in adherent conditions
to assess an impact on differentiation. As in vivo, the vast
majority of VCAM1+ cells in vitro, in neurosphere, or in adherent
cultures are GFAP+ (>95%), and we rarely observed (<1%)
VCAM1 expression on neuroblasts.
shRNA knockdown of Vcam1 had no effect on primary neuro-
sphere formation, but it dramatically reduced secondary neu-
rosphere formation to 44.70% ± 4.47% of control and tertiary
neurosphere formation to 29.84% ± 2.39% of control (***p <
0.001) (Figures 4B and 4C). Similarly, blocking with VCAM1 anti-
body did not significantly affect primary neurosphere generation,
but reduced secondary neurosphere formation to just 38.07% ±
6.61% of control (p < 0.01) (Figure 4D). These findings are con-
sistent with Vcam1 being important for maintaining the NSC
state, and the rapid loss of Type B and Type C cells seen after
blocking VCAM1 in vivo would be expected to result in fewer
neurosphere-generating cells, as observed here.
Dissociated cultures of SVZ cells treated with shRNA Vcam1
lentivirus or EV control lentivirus for 4 DIV showed reduced
Nestin+ progenitor cells and fewer cells expressing the prolifer-
ation marker Ki67, but increased numbers of EGFR+ cells, a
marker of activated Type B and Type C cells, and DCX+ Type
A neuroblasts. These observations are consistent with in vivo
results showing that blocking VCAM1 stimulates lineage pro-
gression (Figure 4E). Conversely, addition of exogenous VCAM1
increased expression of NSC markers and decreased expres-
sion of lineage progression markers (Figure S4). Consistent
with this, knockdown of Vcam1 reduced expression of genes
associated with stem cell maintenance (Aguirre et al., 2010;
Fasano et al., 2007, 2009; Imayoshi et al., 2010; Nam and Ben-
ezra, 2009) and upregulated genes associated with lineage
progression and differentiation in this system, which producesell Stem Cell 11, 220–230, August 3, 2012 ª2012 Elsevier Inc. 223
Figure 3. Neuroblast Chain Migration Is Disordered after Blocking VCAM1
(A) Low-magnification images of SVZ wholemounts stained for DCX (magenta).
(B and C) High-magnification images show disrupted neuroblast chains (magenta) and the disrupted GFAP-GFP+ Type B cell layer (green) after VCAM1 block (C)
versus control antibody (B).
(D) High-magnification coronal section shows neuroblast chains (red) outside of the SVZ after VCAM1 block. Dali, blue nuclei. Scale bars: 20 mm. See also
Figure S3.
Cell Stem Cell
VCAM1 Is Essential for the Neural Stem Cell Nichelargely new GABAergic olfactory neurons (Hack et al., 2005)
(Figures 4F and 4G). These data show that VCAM1 function is
critical for SVZ NSC maintenance, and without it, the NSC pop-
ulation rapidly depletes and differentiates.
Activating VCAM1 Increases ROS in SVZ NSCs
VCAM1 can signal through activation of the NADPH oxidase
enzyme NOX2 and production of ROS in endothelial cells, upre-
gulating molecules that alter cell-cell and cell-matrix adhesion
(Cook-Mills, 2002, 2006; Cook-Mills et al., 2011). Interestingly,
it has recently been shown that proliferative NSCs in the SVZ
have high levels of ROS generated by theNOX2 enzyme (Le Belle
et al., 2011), and that this oxidative status is important for main-
tenance of the stem cell state. By immunostaining, we found that
NOX2 and VCAM1 were expressed with a high degree of over-
lap, suggesting that apical processes rich in VCAM1 are also
rich in this enzyme (Figure 5A). To examine a functional associa-
tion, we knocked down Vcam1 in neurosphere-expanded adult
SVZ cells and saw significantly reduced Nox2 expression by
qPCR (Figure 5B).
If VCAM1 functions via NOX2, then we would expect that acti-
vation of VCAM1 would result in increased ROS. To test this, we
generated beads coatedwith the anti-VCAM1antibody, a config-
uration that has been shown to bind, dimerize, and activate
VCAM1 (Deem et al., 2007; Matheny et al., 2000) (in contrast to
the use of the soluble antibody, as described above, which binds
VCAM1 and blocks its interaction with its coreceptor; Baron
et al., 1994). These VCAM1-antibody-activating beads, or beads224 Cell Stem Cell 11, 220–230, August 3, 2012 ª2012 Elsevier Inc.coated with IgG antibodies as control, were overlaid on 4 DIV
adherent adult SVZ cultures in the presence of a ROS sensor
dihydroethidine, which when oxidized binds to DNA and pro-
duces a fluorescent signal (Figure 5D) (Cook-Mills, 2002, 2006).
Treatment of NSCs with VCAM1-activating beads resulted in
a 9.1% increase in ROS sensor fluorescence compared to
control beads (Figures 5C and 5E), indicating that this signal-
ing pathway is downstream of VCAM1. Thus signaling through
VCAM1 increases ROS activity, which is consistent with
VCAM1 helping to maintain the appropriate ROS status benefi-
cial for NSC maintenance and function (Le Belle et al., 2011).
VCAM1 Increases in Response to IL-1b, Acting as an
Environmental Sensor on Type B Cells
In endothelial cells and the bonemarrow stem cell niche, VCAM1
is upregulated by the cytokines interleukin 1b (IL-1b) and SDF1,
an effect that plays an important role in the immune response
(Cook-Mills et al., 2011; Oostendorp and Do¨rmer, 1997). Thus,
upregulation of VCAM1 in endothelium activates signaling cas-
cades that open up the vasculature, allowing immune cells
access to sites of inflammation. IL1 receptor 1 (IL1R1) is found
on the GFAP+ processes of Type B cells in the SVZ (Figure 6A).
Furthermore, IL-1b is expressed by the choroid plexus within the
lateral ventricle near the SVZ (Figure 6B), and it is present in CSF
and upregulates upon injury (Bonneh-Barkay et al., 2010; Chiar-
etti et al., 2005; Gourin and Shackford, 1997; Szmydynger-
Chodobska et al., 2009), suggesting that IL-1b in the environ-
ment could modulate VCAM1 function.
Figure 4. NSC Self-Renewal Depends on VCAM1 Function
(A) qPCR of Vcam1 expression in adult SVZ cells treated with lentiviral shRNA against Vcam1.
(B) Reduced secondary neurosphere formation after Vcam1 shRNA treatment.
(C) Primary, secondary, and tertiary neurosphere formation of the above. ***p < 0.001.
(D) Reduction in secondary sphere formation by SVZ cells treated with VCAM1 blocking antibody versus isotype control antibody. **p < 0.01.
(E) Quantification of immunostained adult SVZ cells in adherent culture shows that Vcam1 knockdown for 7 days reduced Ki67+ proliferating cells and Nestin+
cells and increased EGFR+ and DCX+ cells.
(F and G) qPCR analysis of adult SVZ cells treated with EV or Vcam1 shRNA virus and then grown in neurosphere culture for 14 DIV. (F) Genes implicated in SVZ
NSC maintenance and (G) in NSC differentiation. ***p < 0.001. Error bars = SEM. See also Figure S4.
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VCAM1 expression, we treated neurosphere-expanded cells
from hGFAP-GFP mice (Zhuo et al., 1997) with 10 ng/ml of
SDF1 or IL-1b and used qPCR and flow cytometry to analyze
the effect on VCAM1 expression. Although SDF1 increased
Vcam1message it did not result in an increase in VCAM1 protein
under these conditions (not shown). However, treatment of
neurosphere cells with IL-1b gave a more than 3-fold increase
in Vcam1message measured by qPCR (Figure 6C) and a signifi-
cant increase in VCAM1 protein expression in the GFAP-GFP+
population but not in the GFAP-GFP population (1216 ±
47.48 versus 847 ± 29.13 control, p < 0.01, Figure 6D) when
we measured using flow cytometry. The proportion of cells that
express VCAM1 did not change with IL-1b treatment, but the
signal increased, suggesting that IL-1b treatment increased
VCAM1 expression in cells that were already VCAM1+ (Fig-
ure 6E). Given that reduced VCAM1 resulted in reduced NSC
maintenance and increased Type B cell proliferation and line-
age progression, we tested whether IL-1bwould have an oppos-
ing effect. Indeed, daily treatment with 10 ng/ml IL-1b on
cultured adult SVZ cells increased the number of cells ex-
pressing CD133, a marker associated with SVZ NSCs (Becker-Cvordersandforth et al., 2010; Mirzadeh et al., 2008), and sig-
nificantly reduced the number of MASH1+ Type C cells and
cell proliferation, revealed by lowered Ki67 expression (Fig-
ure 6F). Furthermore, injecting IL-1b directly into the lateral
ventricles of adult mice in vivo resulted in significantly fewer
EdU+ proliferating cells in the SVZ (Figure 6G). These data
support the conclusion that upregulation of VCAM1 via IL-1b
treatment favors maintenance of the NSC state and inhibits
lineage progression.
DISCUSSION
Here we examined the molecular underpinnings responsible for
the highly organized cytoarchitecture of the adult SVZ neuro-
genic zone. Our results indicate that VCAM1 is essential for
maintaining this adult stem cell niche, playing a key role in both
its structure and function by regulating the positioning of Type
B cells and their state of quiescence versus activation. In addi-
tion, VCAM1, which has important roles in inflammation, can
act as an environmental sensor for factors in the CSF or other
humoral compartments, responding to cytokines such as IL-1b
to regulate NSC activity.ell Stem Cell 11, 220–230, August 3, 2012 ª2012 Elsevier Inc. 225
Figure 5. VCAM1 Activation Results in ROS Signaling
(A) Immunostaining shows that NOX2 is expressed in GFAP+ cells closely overlapping with VCAM1+ staining.
(B) qPCR analysis shows that Nox2 expression is reduced after lentiviral Vcam1 knockdown versus EV control. ***p < 0.001.
(C) Phase contrast and fluorescent images of 4 DIV adult SVZ cells treated with a ROS sensor in the presence of anti-VCAM1-activating beads or control
IgG beads.
(D) Diagram of the experimental design.
(E) Analysis of fluorescence intensity shows that VCAM1 activation increases ROS production. Scale bars: 20 mm. Error bars = SEM.
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VCAM1 Is Essential for the Neural Stem Cell NicheVCAM1 is expressed rather specifically by the apical Type B
cells in the SVZ, displaying one of the cleanest expression
patterns discovered to date for these cells. The small fraction
of cells that express VCAM1 but are GFAP in tissue culture
remains to be identified and may be a consequence of in vitro
manipulation as these were not seen in vivo. The fact that
VCAM1 is expressed by radial glia in the embryo (Sheppard
et al., 1995) and enriched in the most primitive cells in the VZ
during development (Kawaguchi et al., 2008) indicates a conti-
nuity of function in CNS progenitor cells throughout life, fitting
with their lineal relationship (Alvarez-Buylla et al., 2001). Interest-
ingly, after blocking VCAM1 in the SVZ, we saw patches of small
neuroblast chains in the striatal parenchyma. Thus, by helping to
maintain the cytoarchitecture, VCAM1 may be important for
restricting germinal cells to the SVZ locale. Alternatively, the
blocking antibody could activate normally dormant cells outside
of the niche, which is worthy of further investigation.
Our data show that VCAM1 is critical for anchoring Type B
cells within the ependymal niche. Type B cells that are closely
apposed to ependymal cells are largely quiescent (Doetsch
et al., 1997, 1999b), and ependymal cells likely secrete specific226 Cell Stem Cell 11, 220–230, August 3, 2012 ª2012 Elsevier Inc.factors that maintain this population in a relatively dormant state.
Other stem cell types such as HSCs and Drosophila germ cells
are similarly dependent on contact with adjacent support cells
to retain stem cell function (Nystul and Spradling, 2007; Xie
and Spradling, 2000). We propose that VCAM1 is a key contrib-
uting factor to adult NSC maintenance by anchoring them close
to factors located at the ependymal surface and controlling their
detachment toward blood vessels that release factors that stim-
ulate NSC lineage progression (Kokovay et al., 2010; Louissaint
et al., 2002). VCAM1 might also help regulate cell-cell junction
formation, and it is interesting that after blocking VCAM1 we
see a marked upregulation of b-catenin and ZO-1, markers of
adherens and tight junctions, respectively. This in turn could
impact themode of division, as junctions can regulate symmetric
versus asymmetric division in embryonic NSCs (Go¨tz and
Huttner, 2005), which will be a point for future studies. In other
cell types, VCAM1 signals by interacting with alpha4beta1 in-
tegrin (VLA4; Cook-Mills et al., 2011). However, we did not detect
VLA4 expression by qPCR or immunohistochemistry in the SVZ
(not shown), so the counter-ligand for VCAM1 in the SVZ remains
to be elucidated.
Figure 6. IL-1b Upregulates VCAM1 Expression and Inhibits Lineage Progression
(A) A confocal image of an SVZwholemount taken just below the ependymal layer where the majority of Type B cells reside, showing that a subset of GFAP-GFP+
cells with radial morphology express IL-1R1.
(B) Confocal image of choroid plexus stained for IL-1b (left) or negative control IgG (right).
(C) qPCR analysis shows increased Vcam1 expression in SVZ cells treated with IL-1b versus vehicle control.
(D) VCAM1 fluorescence intensity measured using flow cytometry. SVZ cells treated with 10 ng/ml IL-1b recombinant protein show increased VCAM1
immunostaining compared to vehicle.
(E) Flow analysis of neurosphere-expanded cells from GFAP-GFP mice treated with IL-1b or vehicle shows no significant differences in subpopulation
composition.
(F) Quantification of positive cells in adherent SVZ cell culture treated with recombinant IL-1b protein or PBS vehicle for 4 DIV.
(G) Quantification of EdU+ cells in the SVZ 18 hr after IL-1b or vehicle injection into the lateral ventricle.*p < 0.05, **p < 0.01, ***p < 0.0001. Scale bars: 20 mm. Error
bars = SEM.
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VCAM1 Is Essential for the Neural Stem Cell NicheIn endothelial cells, VCAM1 signals through NOX2 and ROS
production (Cook-Mills et al., 2011). Although the role of ROS
in inflammation, DNA damage, and cell death is well recognized,
their role as second messengers in activating multiple signaling
cascades is becoming increasingly appreciated (Jiang et al.,
2011; Petry et al., 2010; Vieira et al., 2011). Induction of ROS
generation by cell surface receptors such as FGFR1–4,
PDGFRa/b, and VEGFR2, which have been implicated in neural
stem and progenitor cell proliferation, occurs via the NOX
enzymes (Petry et al., 2010). In a prior study, it was shown that
ROS stimulation increased neurogenesis and self-renewal in
cultured SVZ NSCs that are in an activated state, and treatment
with antioxidants interfered with self-renewal by reducing ROS
production and subsequently reducing PI3K/AKT pathway
activity (Le Belle et al., 2011). It was suggested that quiescent
NSCs in vivo might have low ROS levels, but that once activated,
high ROS levels ensured sustained self-renewal while generating
differentiated progeny. Our findings are consistent with a role for
ROS in NSC maintenance and quiescence, downstream of
VCAM1. It is possible that VCAM1 helps maintain a level of
ROS compatible with NSC quiescence, and that abnormally
low or high levels are detrimental to NSC function in the niche.
The fact that the NSCs respond to factors that also potently
act on endothelial cells is interesting given the importance of
the vascular niche to stem cell function (Louissaint et al., 2002;
Palmer et al., 2000; Shen et al., 2004). Although we did not
observe any marked changes in the SVZ vascular plexus after
VCAM1 block in vivo (not shown), it is possible that this manipu-
lation, or application of IL-1b, alters endothelial permeability and
thereby the release of factors that impact NSC activity.CThe proximity of VCAM1-rich apical endings to the CSF in the
lateral ventricle allows them to serve as detectors of CSF
changes. Rather little is known about how the CSF regulates
NSCs, but the fact that it contains multiple growth factors,
chemokines, and cytokines, and that its composition varies
with age and disease (Emerich et al., 2005; Johanson et al.,
2008, 2011; Veening and Barendregt, 2010), implies that it is
an important regulatory compartment for NSC homeostasis.
For example, IL-1b is secreted into the CSF and increases with
inflammation, age, and Alzheimer’s disease (Cacabelos et al.,
1991; Marques et al., 2007; Sun et al., 2009).
In our study, we found that increased IL-1b stimulates VCAM1
levels on NSCs and reduces proliferation and prevents line-
age progression, which is somewhat counterintuitive because
damage-associated cytokines might be expected to stimulate
stem cell differentiation to aid tissue repair. However, it is also
possible that this effect helps preserve NSCs, preventing their
large-scale activation and depletion. In addition, upregulation
of VCAM1 could play a protective role in maintaining the integrity
of the ependymal zone during inflammation. It will be interesting
to examine whether VCAM1 in the adult NSC niche can promote
leukocyte adhesion, thus attracting them from the CSF to areas
of CNS damage, because while the white blood cell count in the
CSF is normally low, it can increase in CNS infections and be
protective (Ransohoff et al., 2003).
In the other major adult neurogenic zone, the hippocampal
dentate gyrus, increased IL-1b reduces proliferation and neuro-
genesis in young and old mice, and contributes to reduced neu-
rogenesis after stress (Koo and Duman, 2008; Koo et al., 2010;
Kuzumaki et al., 2010; Luo et al., 2008). Reducing IL-1b canell Stem Cell 11, 220–230, August 3, 2012 ª2012 Elsevier Inc. 227
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VCAM1 Is Essential for the Neural Stem Cell Nicheincrease hippocampal neurogenesis in aging (Gemma et al.,
2007) but decrease injury-induced increased neurogenesis
(Spulber et al., 2008). Thus it appears that IL-1b has an important
role in regulating hippocampal neurogenesis and can have
opposing effects depending on the context. It will be worthwhile
to examine whether VCAM1 is also an important mediator of
NSC function in the hippocampus in vivo during disease and
aging, given that it interacts with IL-1b to regulate neurogenesis
in hippocampal NSC cultures (Barkho et al., 2006).
Understanding the impact and mechanism of action of neu-
roinflammatory molecules on adult stem cell niches is important
to determine the consequences on adult neural cell genesis. For
example, our data suggest that chronic impairment of VCAM1
function would lead to NSC depletion, and it is tempting
to suggest that such a mechanism could help explain why
prolonged inflammation eventually leads to memory deficits
(Bettcher et al., 2011). In addition to regulation via cytokines,
VCAM1 function is modulated by molecules such as bilirubin,
vitamin E, and metalloproteinases (Cook-Mills et al., 2011), and
VCAM1 can be cleaved, releasing the ectodomain, which binds
and activates its receptor (Garton et al., 2006). Hence there are
a number of ways in which VCAM1 function could be manipu-
lated to augment NSC maintenance to offset deficits due to
aging or disease.
EXPERIMENTAL PROCEDURES
SVZ Wholemount Dissection
Adult 2- to3-month-oldSwissWebstermice (TaconicFarms), hGFAP-GFPtrans-
genic mice (FVB/N-Tg(GFAPGFP)14Mes/J, Jackson Laboratory), or Mash1-
Cre-Tomato mice (Ascl1tm1.1(cre/ERT2); B6.Cg-Gt(ROSA)26Sortm9(CAG-tdTomato);
Kim et al., 2011) were sacrificed and SVZ wholemounts were dissected, as
described (Doetsch et al., 1999a; Lois and Alvarez-Buylla, 1993). Briefly,
a 2–4 mm long strip of SVZ tissue of the striatal wall was dissected, from under
the corpus callosum to the ventral tip of the lateral ventricle. The SVZ whole-
mounts were fixed in cold 4% paraformaldehyde in 0.1 M PBS for 30 min and
washed with PBS before staining.
Adult SVZ Cell Culture
SVZs were dissected from Swiss Webster or hGFAP-GFP mice, incubated in
100 U papain in DMEM at 37C on a shaker for 45 min, and gently triturated.
Dissociated cells were washed 33 in PBS with centrifugation at 400 3 g at
4C. For adherent cultures, cells were seeded in poly-l-ornithine (Sigma)
coated 24-well plates (Corning) or Terasaki plates (Nunc) at 40,000, 2,000,
or 200 cells per well in serum-free culture medium as described (Kokovay
et al., 2010).
The neurosphere assays to test self-renewal were conducted as described
(Pastrana et al., 2011). Briefly, cells were cultured in ultra-low attachment
6-well plates (Corning) at three cells/ml for primary spheres and one cell/ml
for secondary spheres in serum-free culture medium with 20 ng/ml of FGF2
and 20 ng/ml EGF (Invitrogen). For treatment with recombinant proteins, neu-
rospheres were dissociated with 50U papain in 5mls DMEM for 30min at 37C
on a shaker, washed 33 with PBS, and treated with 1 mg/ml VCAM1 protein,
10 ng/ml IL-1b, or 10 ng/ml SDF1 (Peprotech) overnight.
Vcam1 Lentiviral shRNA Preparation
An shRNA was designed (Dharmacon) and plasmids were generated by
insertion of the hairpin oligonucleotides into the FUGW-H1 lentiviral construct
(Fasano et al., 2007). To package, the lentiviral constructs were cotransfected
using Superfect (QIAGEN) with pCMV-VSVG and pCMV-DVPR into 293FT
cells grown under selective conditions. Supernatant was harvested 2 and
3 days later and was concentrated by ultracentrifugation. Lentiviruses were
used at 10 multiplicity of infection (MOI) for cell transduction. The oligonucle-
otide sequence targeting Vcam1 was 50 GACTGACTGTTGTAACTTA 30.228 Cell Stem Cell 11, 220–230, August 3, 2012 ª2012 Elsevier Inc.FACS Analysis
Neurospheres from GFAP-GFP or Swiss Webster (for negative control of GFP
signal) mice were dissociated and treated with 10 ng/ml mouse recombinant
IL-1b, SDF1, or vehicle (PBS) overnight. On ice, cells (60,000 cells per condi-
tion, n = 3) were blocked with heat-inactivated FBS for 15 min and incubated
with 0.2 mg/ml Alexa Fluor 647 conjugated anti-mouse VCAM1 or isotype
control (eBioscience). Gates were set manually using the negative controls.
The fluorescence intensity and mean number of positive cells were measured
onBDBiosciences FACSAria II and the percentage of positive cells was deter-
mined for each phenotype.
VCAM1 Activating Beads and ROS Detection
Beads were coated with IgG or anti-VCAM1 as described (Deem et al., 2007;
Matheny et al., 2000). Briefly, 10 mm diameter streptavidin-coated micro-
spheres (80 ml/ sample, Bangs Laboratories) were labeled with 24 mg biotin-
conjugated goat anti-rat IgG, washed 33 in PBS by centrifugation, and then
incubated with 16 mg rat anti-VCAM1 or isotype control antibody at 4C for
1 hr. The beads were washed 33 in PBS and resuspended in PBS. Adult
SVZ cells were grown in adherent culture for 4 DIV then incubated in 2 mM of
the ROS sensor dihydroethidium in culture medium with no anti-oxidants
(n = 3 per condition). Antibody coated beads were added to each well. After
30 min, five fields of view were captured using a 203 objective. The pixel
strength of each cell nucleus was measured using ImageJ software (Ferreira
and Rasband, 2011).
EdU Labeling
To label proliferating cells, EdU (Invitrogen) (10 mg/ml solution) was in-
jected intraperitoneally (50 mg/kg) 2 hr before mice were sacrificed. To detect
label-retaining cells and newborn olfactory bulb cells, EdU was injected once
daily for 3 days and mice were sacrificed 3 weeks after the final injection. EdU
was detected using the Click-it Kit (Invitrogen), prior to the performance of
additional immunohistochemistry.
VCAM1 Blocking Experiments
For in vivo VCAM1 blocking, miniosmotic pumps (model 1007D Alzet)
were preloaded with rat anti-mouse VCAM1 antibody (BD Biosciences) or
rat IgG2ak control antibody at 0.5 mg/ml in artificial CSF hGFAP-GFP
or GFAP-GFP-BAC mice (FVB/N-SwissWebster-Tg(GFAPEGFP)CV94Gsat/
Mmmh). Mice were anesthetized with 3% isoflurane and a 3 mm cannula
(Alzet) connected to the pumps was inserted stereotactically into the lateral
ventricle (0.85 mm lateral of Bregma). After 5–7 days of infusion, mice were
sacrificed and the SVZ wholemounts were dissected and fixed for immunos-
taining. For each group, three to five random fields from each wholemount
were imaged using a two-photon Zeiss 510 Meta confocal microscope or a
Leica TCSSP5 II confocal microscope, and datawere pooled from two or three
wholemounts. The number of GFAP-GFP+ cell bodies in the ependymal layer
was counted in a 1 mm z-stack and divided by the field area. Brain sections
for analysis were generated as described in the Supplemental Information.
For in vitro VCAM1 inhibition, neurospheres were treated with 10 mg/ml of
VCAM1 blocking or control antibody for 7 days, and the numbers of neuro-
spheres per well were counted (n = 3–5 per condition). Neurospheres were
dissociated and then incubated for 7 more days in the appropriate antibody
and were quantified.
Statistics
All data are expressed as mean ± SEM. Student’s t test and ANOVA were per-
formed using Graphpad Prism software.
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